Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.63 -0.35 (-3.51%)
As of: Sep 30, 2026 · 12:49 PM EDT

Xeris Biopharma Holdings, Inc. (XERS) Non-Current Debt (2023 - 2026)

Updated

Xeris Biopharma Holdings' Non-Current Debt was $188.81 million in Q2 2026, down 13.6% from $218.63 million a year earlier and down 14.7% from the prior quarter.

Analysis

Xeris Biopharma Holdings, Inc. (XERS) Non-Current Debt (2023 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Debt at Xeris Biopharma Holdings came in at $220.34 million, up 1.5% from FY2024.

  • In earlier years, Non-Current Debt was $217.01 million in FY2024 (+13.7%) and $190.93 million in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Non-Current Debt in data going back to Q4 2023.
  • Compared with a year earlier, Non-Current Debt was higher in three of the last four quarters, with growth averaging 0.8%.
  • Per Business Quant data, XERS's Non-Current Debt in the three quarters before Q2 2026 was $221.22 million (Q1 2026), $220.34 million (Q4 2025) and $219.47 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 188.81 Mn
Mar 31, 2026 221.22 Mn
Dec 31, 2025 220.34 Mn
Sep 30, 2025 219.47 Mn
Jun 30, 2025 218.63 Mn
Mar 31, 2025 217.81 Mn
Dec 31, 2024 217.01 Mn
Dec 31, 2023 190.93 Mn
API Access

Xeris Biopharma Holdings, Inc. Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=XERS&period=max&api_key=YOUR_API_KEY